JW Holdings Corporation (096760.KS)
KRW 3045.0
(0.0%)
KRW 3045.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 554.58 Billion KRW | 0.47% |
| 2022 | 552 Billion KRW | 13.15% |
| 2021 | 487.83 Billion KRW | -7.99% |
| 2020 | 530.2 Billion KRW | -11.07% |
| 2019 | 596.17 Billion KRW | 0.86% |
| 2018 | 591.07 Billion KRW | -19.08% |
| 2017 | 730.43 Billion KRW | 9.2% |
| 2016 | 668.88 Billion KRW | 3.13% |
| 2015 | 648.61 Billion KRW | -2.44% |
| 2014 | 664.83 Billion KRW | 4.12% |
| 2013 | 638.55 Billion KRW | -5.0% |
| 2012 | 672.18 Billion KRW | 3.35% |
| 2011 | 650.36 Billion KRW | 15.36% |
| 2010 | 563.78 Billion KRW | 43.73% |
| 2009 | 392.24 Billion KRW | 25.45% |
| 2008 | 312.66 Billion KRW | 29.05% |
| 2007 | 242.28 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 534.9 Billion KRW | -3.55% |
| 2024 Q2 | 520.41 Billion KRW | -2.71% |
| 2023 Q4 | 554.58 Billion KRW | -8.76% |
| 2023 Q3 | 607.82 Billion KRW | -1.51% |
| 2023 Q2 | 617.13 Billion KRW | -1.14% |
| 2023 FY | 554.58 Billion KRW | 0.47% |
| 2023 Q1 | 624.23 Billion KRW | 13.09% |
| 2022 Q2 | 545.67 Billion KRW | 7.9% |
| 2022 Q3 | 543.88 Billion KRW | -0.33% |
| 2022 Q4 | 552 Billion KRW | 1.49% |
| 2022 Q1 | 505.71 Billion KRW | 3.66% |
| 2022 FY | 552 Billion KRW | 13.15% |
| 2021 FY | 487.83 Billion KRW | -7.99% |
| 2021 Q3 | 479.17 Billion KRW | -1.75% |
| 2021 Q2 | 487.72 Billion KRW | 1.57% |
| 2021 Q1 | 480.18 Billion KRW | -9.43% |
| 2021 Q4 | 487.83 Billion KRW | 1.81% |
| 2020 Q4 | 530.2 Billion KRW | -2.02% |
| 2020 Q1 | 568.13 Billion KRW | -4.7% |
| 2020 FY | 530.2 Billion KRW | -11.07% |
| 2020 Q2 | 566.97 Billion KRW | -0.2% |
| 2020 Q3 | 541.12 Billion KRW | -4.56% |
| 2019 Q1 | 558.34 Billion KRW | -5.54% |
| 2019 Q3 | 568.24 Billion KRW | -1.16% |
| 2019 FY | 596.17 Billion KRW | 0.86% |
| 2019 Q2 | 574.9 Billion KRW | 2.97% |
| 2019 Q4 | 596.17 Billion KRW | 4.92% |
| 2018 Q4 | 591.07 Billion KRW | -4.19% |
| 2018 Q3 | 616.94 Billion KRW | -4.58% |
| 2018 Q2 | 646.53 Billion KRW | -9.72% |
| 2018 Q1 | 716.17 Billion KRW | -1.95% |
| 2018 FY | 591.07 Billion KRW | -19.08% |
| 2017 Q2 | 733.33 Billion KRW | -0.4% |
| 2017 Q4 | 730.43 Billion KRW | 0.59% |
| 2017 FY | 730.43 Billion KRW | 9.2% |
| 2017 Q3 | 726.14 Billion KRW | -0.98% |
| 2017 Q1 | 736.27 Billion KRW | 10.07% |
| 2016 Q3 | 686.72 Billion KRW | 6.07% |
| 2016 FY | 668.88 Billion KRW | 3.13% |
| 2016 Q1 | 584.85 Billion KRW | -9.83% |
| 2016 Q4 | 668.88 Billion KRW | -2.6% |
| 2016 Q2 | 647.43 Billion KRW | 10.7% |
| 2015 Q4 | 648.61 Billion KRW | -1.97% |
| 2015 FY | 648.61 Billion KRW | -2.44% |
| 2015 Q3 | 661.63 Billion KRW | -1.86% |
| 2015 Q2 | 674.18 Billion KRW | 1.46% |
| 2015 Q1 | 664.45 Billion KRW | -0.06% |
| 2014 Q4 | 664.83 Billion KRW | 0.01% |
| 2014 Q3 | 664.78 Billion KRW | -1.02% |
| 2014 FY | 664.83 Billion KRW | 4.12% |
| 2014 Q1 | 659.8 Billion KRW | 3.33% |
| 2014 Q2 | 671.61 Billion KRW | 1.79% |
| 2013 Q3 | 617.65 Billion KRW | 2.46% |
| 2013 Q4 | 638.55 Billion KRW | 3.38% |
| 2013 FY | 638.55 Billion KRW | -5.0% |
| 2013 Q1 | 687.4 Billion KRW | 2.26% |
| 2013 Q2 | 602.83 Billion KRW | -12.3% |
| 2012 FY | 672.18 Billion KRW | 3.35% |
| 2012 Q4 | 672.18 Billion KRW | 0.0% |
| 2011 Q3 | 24.52 Billion KRW | 28.49% |
| 2011 Q1 | 11.85 Billion KRW | 0.0% |
| 2011 Q2 | 19.08 Billion KRW | 61.04% |
| 2011 FY | 650.36 Billion KRW | 15.36% |
| 2010 Q3 | 68.3 Billion KRW | 8.59% |
| 2010 Q2 | 62.9 Billion KRW | 4.66% |
| 2010 Q1 | 60.1 Billion KRW | 0.0% |
| 2010 FY | 563.78 Billion KRW | 43.73% |
| 2009 Q3 | 41.2 Billion KRW | 36.42% |
| 2009 Q1 | 14.8 Billion KRW | 0.0% |
| 2009 FY | 392.24 Billion KRW | 25.45% |
| 2009 Q2 | 30.2 Billion KRW | 104.05% |
| 2008 Q1 | - KRW | 0.0% |
| 2008 Q2 | 3 Billion KRW | 0.0% |
| 2008 FY | 312.66 Billion KRW | 29.05% |
| 2008 Q3 | 3.1 Billion KRW | 3.33% |
| 2007 Q3 | 5.4 Billion KRW | 0.0% |
| 2007 FY | 242.28 Billion KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1307.323% |
| Dong-A Socio Holdings Co., Ltd. | 691.88 Billion KRW | 19.844% |
| Ildong Holdings Co., Ltd. | 382.06 Billion KRW | -45.157% |
| HANDOK Inc. | 300.01 Billion KRW | -84.855% |
| Kukje Pharma Co., Ltd. | 30.66 Billion KRW | -1708.703% |
| Yuhan Corporation | 230.07 Billion KRW | -141.05% |
| Dong-A ST Co., Ltd. | 406.7 Billion KRW | -36.361% |
| SAMSUNG PHARM. Co., LTD. | 595.48 Million KRW | -93031.697% |
| Hanmi Pharm. Co., Ltd. | 572.86 Billion KRW | 3.191% |
| Hanall Biopharma Co.,Ltd | 1.29 Billion KRW | -42873.516% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -551.23% |
| Dong Sung Bio Pharm.Co.,Ltd. | 43.27 Billion KRW | -1181.604% |
| MYUNGMOON Pharm co.,Ltd | 90.48 Billion KRW | -512.923% |
| Hana Pharm Co., Ltd. | 26.53 Billion KRW | -1990.169% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1307.323% |
| Ilsung Pharmaceuticals Co., Ltd. | 238.12 Million KRW | -232796.024% |
| REYON Pharmaceutical Co., Ltd. | 225.05 Billion KRW | -146.424% |
| Aprogen pharmaceuticals,Inc. | 180.99 Billion KRW | -206.406% |
| Ildong Pharmaceutical Co., Ltd. | 217.84 Billion KRW | -154.583% |
| Chong Kun Dang Pharmaceutical Corp. | 219.76 Billion KRW | -152.355% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -225.69% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -1101.666% |
| Hyundai Pharmaceutical Co., Ltd. | 39.2 Billion KRW | -1314.583% |
| Samil Pharmaceutical Co.,Ltd | 175.87 Billion KRW | -215.322% |
| Jeil Pharmaceutical Co.,Ltd | 84.96 Billion KRW | -552.718% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1307.323% |
| Kwang Dong Pharmaceutical Co., Ltd. | 235.64 Billion KRW | -135.352% |
| Daewoong pharmaceutical Co.,Ltd | 469.68 Billion KRW | -18.076% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -225.69% |
| Yuhan Corporation | 230.07 Billion KRW | -141.05% |
| Jeil Pharma Holdings Inc | 173.03 Billion KRW | -220.513% |
| Yungjin Pharm. Co., Ltd. | 66.88 Billion KRW | -729.2% |
| Suheung Co., Ltd. | 467.85 Billion KRW | -18.538% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -225.69% |
| Samjin Pharmaceuticals Co., Ltd. | 118.63 Billion KRW | -367.459% |
| Korea United Pharm Inc. | 40.33 Billion KRW | -1274.812% |
| CKD Bio Corp. | 146.92 Billion KRW | -277.458% |
| Daewon Pharmaceutical Co., Ltd. | 146.04 Billion KRW | -279.724% |
| Dongwha Pharm.Co.,Ltd | 48.25 Billion KRW | -1049.273% |
| Whan In Pharm Co.,Ltd. | 632.02 Million KRW | -87647.403% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -1101.666% |
| Chong Kun Dang Holdings Corp. | 468.03 Billion KRW | -18.493% |
| Boryung Corporation | 204.21 Billion KRW | -171.569% |
| Bukwang Pharmaceutical Co., Ltd. | 79.38 Billion KRW | -598.586% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -551.23% |
| JW Lifescience Corporation | 46.31 Billion KRW | -1097.478% |